Metraipolis › archive › dc_903fe2dd43ef

Efficacy of Kan Jang® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial — Europe PMC PMID:37765004

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37765004
DOI
10.3390/ph16091196
License (as archived)
solo-consultazione
Archived
2026-10-08T01:32:49.385Z
SHA-256 of the archived text
4f3c59294593036f7ed84427fd19e51a17380f441310ee7fbccb6920bb36a2c0
Stable URL of this page
https://metraipolis.com/documento/dc_903fe2dd43ef

How to cite

Efficacy of Kan Jang® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial — Europe PMC PMID:37765004 — Europe PMC (en), https://europepmc.org/article/MED/37765004 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_903fe2dd43ef (Metraipolis archive dc_903fe2dd43ef, sha256 4f3c59294593036f7ed84427fd19e51a17380f441310ee7fbccb6920bb36a2c0)
BibTeX
@misc{dc903fe2dd43ef,
  title = {Efficacy of Kan Jang® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial — Europe PMC PMID:37765004},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37765004},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_903fe2dd43ef; sha256 4f3c59294593036f7ed84427fd19e51a17380f441310ee7fbccb6920bb36a2c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37765004. Agents can read the archived copy with the MCP tool read_document.